Carbonic anhydrase IX in malignant pleural mesotheliomas: A potential target for anti-cancer therapy

被引:11
|
作者
Kivela, Antti J. [1 ]
Knuuttila, Aija [2 ,3 ]
Rasanen, Jari [1 ]
Sihvo, Eero [1 ]
Salmenkivi, Kaisa [4 ,5 ,6 ,7 ]
Saarnio, Juha [8 ]
Pastorekova, Silvia [9 ]
Pastorek, Jaromir [9 ]
Waheed, Abdul [10 ]
Sly, William S. [10 ]
Salo, Jarmo A. [1 ]
Parkkila, Seppo [11 ,12 ,13 ]
机构
[1] Univ Helsinki, Cent Hosp, Div Gen Thorac & Esophageal Surg, Dept Cardiothorac Surg, Helsinki 00029, Finland
[2] Univ Helsinki, Div Pulm Med, Dept Med, Helsinki 00029, Finland
[3] Univ Helsinki, Cent Hosp, Helsinki 00029, Finland
[4] Univ Helsinki, Dept Pathol, FIN-00014 Helsinki, Finland
[5] Univ Helsinki, Mol Canc Biol Res Program, FIN-00014 Helsinki, Finland
[6] Helsinki Univ Hosp, HUSLAB, Helsinki 00014, Finland
[7] Univ Helsinki, Dept Virol, Helsinki 00014, Finland
[8] Oulu Univ Hosp, Dept Surg, Oys 90029, Finland
[9] Slovak Acad Sci, Inst Virol, Ctr Mol Med, Bratislava 84505, Slovakia
[10] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA
[11] Univ Tampere, BioMediTech, Sch Med, FIN-33101 Tampere, Finland
[12] Univ Tampere, Fimlab Ltd, FIN-33101 Tampere, Finland
[13] Tampere Univ Hosp, Tampere, Finland
基金
芬兰科学院;
关键词
Cancer; Carbonic anhydrase; Diagnostics; Expression; Mesothelial cell; Mesothelioma; pH; Pleura; ISOZYME-XII; TUMOR PROGRESSION; POOR-PROGNOSIS; MN/CA IX; EXPRESSION; MARKER; CELLS; FORM;
D O I
10.1016/j.bmc.2012.09.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Malignant mesothelioma is a neoplasm deriving from mesothelial cells, which line the body cavities. The most common type is malignant pleural mesothelioma (MPM), which is a locally aggressive malignancy with poor prognosis. To improve both the clinical diagnostics and treatment it is necessary to identify novel molecular targets which are characteristic for MPM. Although carbonic anhydrase (CA) enzymes have been linked to pH regulation and spread of cancer cells, they have not been thoroughly studied in MPM specimens. We investigated by immunohistochemistry the expression of CA isozymes II, VII, IX, and XII in a series of 27 histological MPM tumor samples. CA IX was absent in the normal lung alveolar cells, whereas it was abundantly expressed in the normal pleural mesothelium and malignant mesothelioma cells. CA VII also showed weak or moderate reactions in several cases of mesotheliomas. Neither high expression of CA VII nor CA IX did correlate significantly with the survival of the patients. The very high expression of CA IX in MPM suggests that it could represent a novel molecular target for cancer research applications. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1483 / 1488
页数:6
相关论文
共 50 条
  • [21] Carborane and metallacarborane inhibitors of carbonic anhydrase IX, promising compounds for cancer therapy
    Brynda, J.
    Rezacova, P.
    Fabry, M.
    Stepankova, J.
    Kral, V.
    Hajduch, M.
    Holub, J.
    Nekvinda, J.
    Pospisilova, K.
    Kugler, M.
    Gruner, B.
    FEBS OPEN BIO, 2018, 8 : 438 - 438
  • [22] Expression of carbonic anhydrase IX suggests poor response to therapy in rectal cancer
    P N Span
    I D Nagtegaal
    J Bussink
    British Journal of Cancer, 2009, 101 : 372 - 372
  • [23] Expression of carbonic anhydrase IX suggests poor response to therapy in rectal cancer
    Span, P. N.
    Nagtegaal, I. D.
    Bussink, J.
    BRITISH JOURNAL OF CANCER, 2009, 101 (02) : 372 - 372
  • [24] Carbonic Anhydrase IX as a Target for Designing Novel Anticancer Drugs
    Monti, S. M.
    Supuran, C. T.
    De Simone, G.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (06) : 821 - 830
  • [25] Carbonic anhydrase II in the endothelium of glial tumors:: A potential target for therapy
    Haapasalo, Joonas
    Nordfors, Kristiina
    Jarvela, Sally
    Bragge, Helena
    Rantala, Immo
    Parkkila, Anna-Kaisa
    Haapasalo, Hannu
    Parkkila, Seppo
    NEURO-ONCOLOGY, 2007, 9 (03) : 308 - 313
  • [26] MEk as a target for anti-cancer therapy
    LoRusso, PM
    ANNALS OF ONCOLOGY, 2006, 17 : 24 - 24
  • [27] TRAIL as a target in anti-cancer therapy
    Wu, Gen Sheng
    CANCER LETTERS, 2009, 285 (01) : 1 - 5
  • [28] Insights into the Role of mTOR/AMPK as a Potential Target for Anti-cancer Therapy
    Ananthram, K. J.
    Rajeev, Mekha
    Aneesh, T. P.
    CURRENT DRUG THERAPY, 2021, 16 (04) : 299 - 312
  • [29] CARBONIC ANHYDRASE IX AS A NOVEL TARGET FOR DETECTION AND THERAPY OF LOW GRADE UROTHELIAL CELL CARCINOMA
    Clebanoff, Jennifer
    Rao, Jian Yu
    Lung, Dominic
    Noe, Mya
    Fung, Po Chu
    Pan, Qin Jing
    Belldegrun, Arie S.
    Pantuck, Allan J.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 70 - 70
  • [30] Hypoxia inducible carbonic anhydrase IX, marker of tumor hypoxia, survival pathway and therapy target
    Potter, C
    Harris, AL
    CELL CYCLE, 2004, 3 (02) : 164 - 167